Event Brief
FDA approves first mRNA flu vaccine for 50+
Filed: Aug 06, 2026 at 12:00 PM ET
Summary: FDA greenlights mFlusiva, the first mRNA flu shot for adults 50 and older, expanding options for seasonal influenza protection.
WHO: FDA; adults age 50+
WHAT: Approval of mFlusiva, the first mRNA flu vaccine for adults 50 and older
WHEN: Aug 06, 2026 at 11:13 AM ET
WHERE: FL
WHY: Routine/scheduled item — no distinct cause reported beyond the event itself.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
🔍 5 sources analyzed
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →